Literature DB >> 10416742

Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma.

D R Anderson1.   

Abstract

It is widely suspected that tissue ischemia initiates or participates in optic disk damage in glaucoma. The details are not well delineated. Particularly puzzling is the clear separation of the clinical appearances of glaucoma and anterior ischemic optic neuropathy, which is also a presumed ischemic disease. When venous pressure at the exit point from the eye is elevated by intraocular pressure (IOP), the arteriovenous pressure difference is reduced. Nutrition is maintained only because of blood flow autoregulation. Intraocular pressure-induced ischemia can result if autoregulation is impaired in an individual, either because of an innate deficiency or, perhaps, as a result of vasospastic disease. Autoregulation can also be impaired if another disease (e.g., an atheroma) has caused much of the autoregulatory capacity to be already utilized, so that little or none is left to respond to the additional challenge of IOP. Ischemia might also result from microvascular occlusion with platelet or clotting abnormalities, perhaps inducing glaucomatous optic neuropathy that is not dependent on IOP. A better understanding of the pathogenic mechanism (and how it may be different in various cases) is needed to predict more successfully an individual's risk of glaucomatous damage, to make decisions about the aggressiveness of treatment, and, one day, to direct therapy at the type of vascular abnormality present, in addition to or instead of lowering IOP.

Entities:  

Mesh:

Year:  1999        PMID: 10416742     DOI: 10.1016/s0039-6257(99)00046-6

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  28 in total

Review 1.  A hypothesis to explain ganglion cell death caused by vascular insults at the optic nerve head: possible implication for the treatment of glaucoma.

Authors:  N N Osborne; J Melena; G Chidlow; J P Wood
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

Review 2.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

3.  Retinal vascular diameter in young subjects with a vasospastic propensity.

Authors:  Fabrizio Branca; Selim Orgül; Claudia Zawinka; Graziella Reinhard; Josef Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

4.  Static blood flow autoregulation in the optic nerve head in normal and experimental glaucoma.

Authors:  Lin Wang; Claude F Burgoyne; Grant Cull; Simon Thompson; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-10       Impact factor: 4.799

5.  Parametric transfer function analysis and modeling of blood flow autoregulation in the optic nerve head.

Authors:  Jintao Yu; Yi Liang; Simon Thompson; Grant Cull; Lin Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2014-03-13

6.  Correlation between ocular perfusion pressure fluctuation and glaucoma severity.

Authors:  Ana Paula Chaves de Oliveira; Niro Kasahara
Journal:  Int Ophthalmol       Date:  2014-03-19       Impact factor: 2.031

7.  Y-27632, a Rho-associated protein kinase inhibitor, attenuates neuronal cell death after transient retinal ischemia.

Authors:  Akira Hirata; Masaru Inatani; Yasuya Inomata; Naoko Yonemura; Takahiro Kawaji; Megumi Honjo; Hidenobu Tanihara
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-31       Impact factor: 3.117

8.  Longitudinal alterations in the dynamic autoregulation of optic nerve head blood flow revealed in experimental glaucoma.

Authors:  Lin Wang; Grant Cull; Claude F Burgoyne; Simon Thompson; Brad Fortune
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

9.  Blood pressure, perfusion pressure, and open-angle glaucoma: the Los Angeles Latino Eye Study.

Authors:  Farnaz Memarzadeh; Mei Ying-Lai; Jessica Chung; Stanley P Azen; Rohit Varma
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

10.  Increased isolevuglandin-modified proteins in glaucomatous astrocytes.

Authors:  Bharathi Govindarajan; Anna Junk; Mabel Algeciras; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  Mol Vis       Date:  2009-06-01       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.